BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1780465)

  • 1. [The prognostic factors for the radiation treatment of the cerebral metastases from breast carcinoma].
    Busetto M; Polico R; Antonello M; Conte G; Masato M; Ravenna C; Bruscagnin A
    Radiol Med; 1991 Nov; 82(5):652-7. PubMed ID: 1780465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
    Nieder C; Andratschke N; Grosu AL; Molls M
    Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CNS metastases in malignant melanomas].
    Willner J; Bohndorf W
    Strahlenther Onkol; 1995 Mar; 171(3):165-73. PubMed ID: 7709333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphopenia: a new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma.
    Claude L; Perol D; Ray-Coquard I; Petit T; Blay JY; Carrie C; Bachelot T
    Radiother Oncol; 2005 Sep; 76(3):334-9. PubMed ID: 16024123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
    Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
    Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
    Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
    Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.
    Rades D; Dunst J; Schild SE
    Strahlenther Onkol; 2008 May; 184(5):251-5. PubMed ID: 18427755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
    Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
    Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Does primary tumor affect the prognosis in postmastectomy locoregional recurrence in breast carcinoma?].
    Willner J; Kiricuta IC; Kölbl O
    Strahlenther Onkol; 1995 Jan; 171(1):18-28. PubMed ID: 7839301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of radiotherapy in brain metastasis].
    Schultze J; Kaya A; Kimmig B
    Rontgenpraxis; 2000; 53(3):102-9. PubMed ID: 11131110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain metastases in breast cancer: prognostic factors and management.
    Lee SS; Ahn JH; Kim MK; Sym SJ; Gong G; Ahn SD; Kim SB; Kim WK
    Breast Cancer Res Treat; 2008 Oct; 111(3):523-30. PubMed ID: 17990100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting the prognosis of breast cancer patients with brain metastases.
    Saip P; Cicin I; Eralp Y; Kucucuk S; Tuzlali S; Karagol H; Aslay I; Topuz E
    Breast; 2008 Oct; 17(5):451-8. PubMed ID: 18455400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival after brain metastases in breast cancer.
    Kocher M; Müller RP; Staar S; Degroot D
    Strahlenther Onkol; 1995 May; 171(5):290-5. PubMed ID: 7770785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radiation therapy in brain metastases].
    Tsuchiya M; Shinozaki J; Hashida I; Kawaguchi T; Yamashita T; Kaneta K
    Gan No Rinsho; 1989 Jan; 35(1):9-14. PubMed ID: 2493528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stereotaxic irradiation of brain metastasis in elderly patients].
    Noël G; Noël S; Feuvret L; Valery CA; Cornu P; Boisserie G; Hasboun D; Tep B; Delattre JY; Baillet F; Mazeron JJ
    Bull Cancer; 2003 Oct; 90(10):896-904. PubMed ID: 14706918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cerebral metastases from breast cancer with stereotactic radiosurgery.
    Combs SE; Schulz-Ertner D; Thilmann C; Edler L; Debus J
    Strahlenther Onkol; 2004 Sep; 180(9):590-6. PubMed ID: 15378190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.